Description: Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. The company provides analgesic / anti-inflammatory patches; athlete's foot / ringworm remedy products; allergy-only rhinitis drugs; eye drops; high cholesterol improving drugs; acne remedies; cooling sheets; and supporters for knee, waist, elbow, calf and ankle. It also provides cooling sprays; bactericidal antibacterial spray and deodorant spray; ship fixing sheet; adhesive plasters for magnetic products; skin care products; sweat sheet; massage roller gel and oil spray; thermal equipment, and dietary supplements. The company offers its products under the Salon pass, Salonship, Air Salon Pass, Fatus, Butena Rock, Allegra, Direct pasting, Choleston, Life Cera, Deco Deco Cool, Children Robin Eye Plus. Eye cool, MSM, and other brand names. It sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Home Page: www.hisamitsu.co.jp
Tashirodaikan-machi 408
Tosu,
841-0017
Japan
Phone:
81 3 5293 1720
Officers
Name | Title |
---|---|
Mr. Kazuhide Nakatomi | President, CEO & Director |
Mr. Nobuo Tsutsumi | GM of Legal Dept, Prod Environment, Reliability Assurance & Comp Manager, Executive Off and Dir |
Kazunori Ito | Executive Officer & GM of Human Resources Department |
Mr. Kyu Saito | MD, Executive Officer, GM of Global Business & Director |
Mr. Shinichi Murayama | Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director |
Mitsutoshi Tsuruta | Executive Officer & Head of Ethical Division |
Masaya Okuno | Executive Officer and Head of Sales & Marketing Division, OTC |
Mr. Koji Takiyama | Executive Officer, GM of President's Office & Director |
Katsuhiko Akiyama | Sr. Exe. Officer & GM of MN Commercialization Office |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 20.8127 |
Price-to-Book MRQ: | 1.1032 |
Price-to-Sales TTM: | 0.0136 |
IPO Date: | |
Fiscal Year End: | February |
Full Time Employees: | 2759 |